With a novel payment approach called the Oncology Care Model (OCM), the Centers for Medicare & Medicaid Services (CMS) hopes to use financial incentives to drive improvements that result in higher-quality, better-coordinated and lower-cost cancer care for Medicare patients receiving chemotherapy.
“Essentially, it’s paying physicians for management of patients,” Debra Patt, MD, MPH, MBA, a practicing oncologist and vice president of Texas Oncology, in Austin, told Clinical